|
| Shaun J Grannis | From the Centers for Disease Control and Prevention COVID-19 Response Team, E.A.-B.) the Division of Infectious Diseases and Clinical Epidemiology, J.A.) the Center for Biomedical Informatics, Regenstrief Institute (S.G., Indiana University School of Medicine (S.G.), and Indiana University Richard M. Fairbanks School of Public Health (B.E.D., P.S.) the Kaiser Permanente Northwest Center for Health Research, University of Colorado, M.B.) HealthPartners Institute, Columbia University Irving Medical Center (K.N., and New York-Presbyterian Hospital (K.N.) - both in New York the Vaccine Study Center, Kaiser Permanente Northern California, Texas A&M University College of Medicine |
| Toan C Ong | From the Centers for Disease Control and Prevention COVID-19 Response Team, E.A.-B.) the Division of Infectious Diseases and Clinical Epidemiology, J.A.) the Center for Biomedical Informatics, Regenstrief Institute (S.G., Indiana University School of Medicine (S.G.), and Indiana University Richard M. Fairbanks School of Public Health (B.E.D., P.S.) the Kaiser Permanente Northwest Center for Health Research, University of Colorado, M.B.) HealthPartners Institute, Columbia University Irving Medical Center (K.N., and New York-Presbyterian Hospital (K.N.) - both in New York the Vaccine Study Center, Kaiser Permanente Northern California, Texas A&M University College of Medicine |
| Karthik Natarajan | From the Centers for Disease Control and Prevention COVID-19 Response Team, E.A.-B.) the Division of Infectious Diseases and Clinical Epidemiology, J.A.) the Center for Biomedical Informatics, Regenstrief Institute (S.G., Indiana University School of Medicine (S.G.), and Indiana University Richard M. Fairbanks School of Public Health (B.E.D., P.S.) the Kaiser Permanente Northwest Center for Health Research, University of Colorado, M.B.) HealthPartners Institute, Columbia University Irving Medical Center (K.N., and New York-Presbyterian Hospital (K.N.) - both in New York the Vaccine Study Center, Kaiser Permanente Northern California, Texas A&M University College of Medicine |
| Suchitra Rao | From the Centers for Disease Control and Prevention COVID-19 Response Team, E.A.-B.) the Division of Infectious Diseases and Clinical Epidemiology, J.A.) the Center for Biomedical Informatics, Regenstrief Institute (S.G., Indiana University School of Medicine (S.G.), and Indiana University Richard M. Fairbanks School of Public Health (B.E.D., P.S.) the Kaiser Permanente Northwest Center for Health Research, University of Colorado, M.B.) HealthPartners Institute, Columbia University Irving Medical Center (K.N., and New York-Presbyterian Hospital (K.N.) - both in New York the Vaccine Study Center, Kaiser Permanente Northern California, Texas A&M University College of Medicine |
| Jill M Ferdinands | From the Centers for Disease Control and Prevention COVID-19 Response Team, E.A.-B.) the Division of Infectious Diseases and Clinical Epidemiology, J.A.) the Center for Biomedical Informatics, Regenstrief Institute (S.G., Indiana University School of Medicine (S.G.), and Indiana University Richard M. Fairbanks School of Public Health (B.E.D., P.S.) the Kaiser Permanente Northwest Center for Health Research, University of Colorado, M.B.) HealthPartners Institute, Columbia University Irving Medical Center (K.N., and New York-Presbyterian Hospital (K.N.) - both in New York the Vaccine Study Center, Kaiser Permanente Northern California, Texas A&M University College of Medicine |
| Stephanie J Schrag | From the Centers for Disease Control and Prevention COVID-19 Response Team, E.A.-B.) the Division of Infectious Diseases and Clinical Epidemiology, J.A.) the Center for Biomedical Informatics, Regenstrief Institute (S.G., Indiana University School of Medicine (S.G.), and Indiana University Richard M. Fairbanks School of Public Health (B.E.D., P.S.) the Kaiser Permanente Northwest Center for Health Research, University of Colorado, M.B.) HealthPartners Institute, Columbia University Irving Medical Center (K.N., and New York-Presbyterian Hospital (K.N.) - both in New York the Vaccine Study Center, Kaiser Permanente Northern California, Texas A&M University College of Medicine |
| Jennifer R Verani | From the Centers for Disease Control and Prevention COVID-19 Response Team, E.A.-B.) the Division of Infectious Diseases and Clinical Epidemiology, J.A.) the Center for Biomedical Informatics, Regenstrief Institute (S.G., Indiana University School of Medicine (S.G.), and Indiana University Richard M. Fairbanks School of Public Health (B.E.D., P.S.) the Kaiser Permanente Northwest Center for Health Research, University of Colorado, M.B.) HealthPartners Institute, Columbia University Irving Medical Center (K.N., and New York-Presbyterian Hospital (K.N.) - both in New York the Vaccine Study Center, Kaiser Permanente Northern California, Texas A&M University College of Medicine |
| Manjusha Gaglani | From the Centers for Disease Control and Prevention COVID-19 Response Team, E.A.-B.) the Division of Infectious Diseases and Clinical Epidemiology, J.A.) the Center for Biomedical Informatics, Regenstrief Institute (S.G., Indiana University School of Medicine (S.G.), and Indiana University Richard M. Fairbanks School of Public Health (B.E.D., P.S.) the Kaiser Permanente Northwest Center for Health Research, University of Colorado, M.B.) HealthPartners Institute, Columbia University Irving Medical Center (K.N., and New York-Presbyterian Hospital (K.N.) - both in New York the Vaccine Study Center, Kaiser Permanente Northern California, Texas A&M University College of Medicine |